[Chemotherapy of epitheliomas of the otorhinolaryngological and cervicofacial area using bleomycin].
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003035:Cobalt / Q000627:therapeutic use; D004428:Ear Neoplasms / Q000188:drug therapy*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005153:Facial Neoplasms / Q000188:drug therapy*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007263:Infusions, Parenteral; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D008171:Lung Diseases / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009669:Nose Neoplasms / Q000188:drug therapy*; D014945:Wound Healing
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D003035:Cobalt
Chimiothérapie à la bléomycine des épithéliomas de la sphère O.R.L. et cervico-faciale.